Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care (Support-t)
Diabetes Mellitus, Diabetes Mellitus, Type 1, Glucose Metabolism Disorders (Including Diabetes Mellitus)
About this trial
This is an interventional supportive care trial for Diabetes Mellitus focused on measuring Transition Care, Pediatric, Adolescent, Education, Hemaglobin A1c, Self-management, Randomized Controlled Trial
Eligibility Criteria
Inclusion Criteria: Adolescents with a clinical diagnosis of T1D 14-16 years of age Receiving diabetes care at one of 4 university teaching hospital-based pediatric diabetes clinics in Quebec: Montreal Children's Hospital-McGill University Health Centre, Centre hospitalier universitaire de Sherbrooke, Le Copain-Hôpital de Gatineau, Centre Hospitalier Universitaire de Québec Having access to internet Having an active email address Fluent in English or French Exclusion Criteria: Severe neurocognitive disabilities Patients with conditions associated with shortened erythrocyte survival, such as hemolytic anemia or other conditions associated with inaccurate HbA1c
Sites / Locations
- Clinique de pédiatrie Le Copain-Hôpital de Gatineau
- Montreal Children's Hospital - McGill University Health Centre
- Centre Hospitalier Universitaire de Québec
- Centre Hospitalier Universitaire de Sherbrooke
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Support-t plus usual diabetes care
Usual diabetes care only
Access to the Support-t online training and peer support platform in addition to usual diabetes care for 18 months. Support-t contains 3 components: 1) Educational material, 2) News blog and 3) Patients' discussion forum. Health care providers from the pediatric diabetes clinics will receive Support-t training and will be encouraged to recommend the Support-t platform during routine care with their patients from the active arm.
Usual diabetes care for 18 months, which consists of visits with their health care provider and ad-hoc diabetes education with nurses and dietitians. Health care providers from the pediatric diabetes clinics will be instructed not to discuss or refer to the Support-t platform with patients from the control arm. Control arm participants will have the option to use the Support-t platform after the 18-month study.